Sio Capital Management, LLC is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.
Filed | Shares | Percentage | |
---|---|---|---|
Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
Brickell Biotech, Inc. | February 14, 2020 | ? | ? |
Trillium Therapeutics Inc. | February 14, 2020 | 2,751,186 | 9.8% |
ZAFGEN, INC. | February 14, 2020 | 2,283,164 | 6.1% |
VICAL INC | February 14, 2019 | 1,615,887 | 7.4% |
CATALYST BIOSCIENCES, INC. | February 14, 2018 | 202,281 | 3.5% |
Quotient Ltd | February 14, 2018 | 1,426,125 | 3.1% |
Adamis Pharmaceuticals Corp | February 14, 2017 | 1,051,063 | 4.9% |
THRESHOLD PHARMACEUTICALS INC | February 14, 2017 | ? | ? |